BIIB

Biogen Inc (BIIB) 2Q21 Earnings Call

Biogen Inc (NASDAQ: BIIB) Q2 2021 Earnings Conference

Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?

Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for…

Biogen Inc. (BIIB) Q1 2021 Earnings Call Transcript

Biogen Inc. (NASDAQ: BIIB) Q1 2021 earnings call dated Apr. 22, 2021 Corporate Participants: Mike Hencke — Director of Investor Relations Michel…

Infographic: How Biogen (BIIB) performed in Q1 2021

Biogen Inc. (NASDAQ: BIIB) reported first quarter 2021 earnings results today. Total revenues decreased 24% year-over-year to $2.6 billion. On…

Biogen Inc (BIIB) Q1 2021 Earnings Call

Biogen Inc (NASDAQ: BIIB) Q1 2021 Earnings Conference

Biogen, Inc. (BIIB) Q4 2020 Earnings Call

Biogen, Inc. (NASDAQ: BIIB) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Mike Hencke — Director, Investor Relations Michel Vounatsos — Chief Executive…

Biogen, Inc. (BIIB) Q4 2020 Earnings Call Transcript

Biogen, Inc. (NASDAQ: BIIB) Q4 2020 earnings call dated Feb. 03, 2021 Corporate Participants: Mike Hencke — Director, Investor Relations Michel Vounatsos — Chief…

Infographic: Key financials of Biogen (BIIB) Q4 2020 earnings report

Biogen (NASDAQ: BIIB) reported fourth-quarter 2020 financial results before the opening bell on Wednesday. The biotechnology giant reported a 22%…

Biogen (BIIB) might need to revisit pipeline after Alzheimer’s drug setback

The controversy surrounding biotechnology firm Biogen’s (NASDAQ: BIIB) Alzheimer’s drug Aducanumab took a positive turn last week after the FDA…

Biogen Inc. (BIIB) Q3 2020 Earnings Call Transcript

Biogen Inc. (NASDAQ: BIIB) Q3 2020 earnings call dated Oct. 21, 2020 Corporate Participants: Joe Mara — Head of Investor Relations Michel Vounatsos — Chief…